Germany rejects U.S. proposal to waive patents on Covid-19 vaccines

Germany on Thursday rejected a U.S. proposal to waive patent protection for Covid-19 vaccines, saying the greatest constraints on production were not intellectual property but increasing capacity and ensuring quality. President Joe Biden on Wednesday voiced support for a waiver in a sharp reversal of the U.S. position, and his top trade negotiator, Katherine Tai, swiftly backed negotiations at the World Trade Organization.
Read more...

;